Vaxfab enterprises Limited has successfully completed the allotment of 2,22,011 equity shares through warrant conversion, as announced by the company's board of directors on February 2, 2026. The allotment represents a significant capital raising exercise that has expanded the company's equity base.

Allotment Details

The board meeting, held on February 2, 2026, approved the allotment of equity shares with a face value of Rs. 10 each at a price of Rs. 21.02 per share. These shares were issued upon conversion of warrants into fully paid-up equity shares on a preferential basis to three investors.

Impact on Share Capital

Following the warrant conversion, the company's paid-up equity share capital has increased substantially. The newly allotted equity shares rank pari-passu in all respects with the existing equity shares of the company, ensuring equal rights and privileges for all shareholders.

Warrant Conversion Details

The warrant conversion process involved a two-stage payment mechanism. Initially, warrant holders paid Rs. 5.255 per warrant at the time of allotment, followed by Rs. 15.765 per warrant at the time of conversion into equity shares, totaling Rs. 21.02 per share.

Investor-wise Conversion

The conversion process shows that while two HUF entities completely converted their warrant holdings, Kushmanda Tradeline LLP exercised only a portion of its warrants, retaining 9,19,760 warrants for potential future conversion. The warrants had a tenure not exceeding 18 months from the date of original allotment.

Regulatory Compliance

The allotment was conducted in compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The board meeting commenced at 6.00 P.M. and concluded at 6.30 P.M. on February 2, 2026, with all necessary approvals obtained for the warrant conversion process.

Vaxfab enterprises announced the allotment of 34,39,136 equity shares through warrant conversion on January 26, 2026, marking a significant capital expansion for the Gujarat-based company. The Board of Directors approved the conversion at their meeting held on January 26, 2026, which commenced at 4:00 PM and concluded at 4:30 PM.

Share Allotment Details

The company allotted equity shares with the following specifications:

The equity shares were issued upon exercise of outstanding equity share warrants, which were originally issued through preferential allotment. The warrant exercise involved payment of Rs. 15.765 per warrant, as the initial Rs. 5.255 was paid at the time of warrant allotment.

Investor-wise Allocation

The warrant conversion was distributed among five investors as follows:

Correction of Earlier Errors

The company also addressed typographical errors in previous submissions dated January 12, 2026 and January 13, 2026. The corrections involved:

• Mr. Rakesh Shamji Patel: Corrected from 95,148 to 95,147 shares
• Mr. Sameet Khatri: Corrected from 118,997 to 118,934 shares
• Ms. Mita Hitesh Ajmera: Corrected from 237,874 to 237,869 shares

These corrections resulted in a change to the total number of shares allotted in the earlier tranches to 2,127,620 shares.

Impact on Share Capital

Following the warrant conversion, Vaxfab Enterprises' capital structure has been enhanced:

The newly allotted equity shares rank pari-passu in all respects with the existing equity shares of the company, ensuring equal rights and privileges for all shareholders.

Regulatory Compliance

The allotment was conducted in accordance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The warrant conversion was completed within the stipulated tenure of 18 months from the date of original warrant allotment, ensuring compliance with regulatory requirements. The company has informed both BSE Limited and The Calcutta Stock Exchange Limited about this development as part of its disclosure obligations.